NANOFH — Nanoform Finland Oyj Share News
0.000.00%
Last trade - 00:00- €63.63m
- €51.03m
- €3.55m
Brief: Herantis Pharma And Nanoform Enter Collaboration Agreement
Brief: Nanoform Says Clinical Study Indicates Positive Interim Results
Brief: Nanoform Sets New Near-Term Business Target For 2021
Brief: Nanoform Completes First Dosing Of Nanoformed Drug
Brief: Herantis Pharma And Nanoform Sign A Letter Of Intent For Collaboration
Brief: Nanoform Finland Q3 Operating Loss Widens To EUR 3.8 Million
Brief: Nanoform Finland Q2 Operating Loss Widens To EUR 6.6 Mln